Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
207.50    2.00 (0.97%)
Bid:
207.50
Ask:
208.50
Spread: 1.00 (0.482%)
Market Cap: £552.34m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

£20m Share Buyback Programme

10 Mar 2026 07:01

RNS Number : 9454V
Costain Group PLC
10 March 2026
 

 

10 March 2026

On-market Share Buyback Programme of £20m

 

Costain Group PLC ("Costain" or the "Group") today announces the launch of an on-market share buyback programme (the "Buyback") for a maximum aggregate consideration of £20m.

This follows the intention set out in the announcement dated 26 January 2026, which provided an update on the Group's new pension scheme agreement, enhanced shareholder returns and FY 25 trading. The removal of the dividend parity arrangement, as announced in the update, removed a significant constraint that was on Costain in respect of returns to shareholders.

Having considered the new agreement, the Group's cash performance and ongoing capital requirements, the Board has concluded that an on-market share buyback programme for a maximum aggregate consideration of £20m (excluding stamp duty and expenses) is an appropriate and value-enhancing use of cash, while maintaining the Group's financial flexibility to continue to invest in its strategy to deliver sustainable growth and attractive returns.

Any ordinary shares purchased by the Company will be cancelled and, accordingly, the Buyback will reduce the Company's share capital.

Details of the Buyback

Costain has instructed Panmure Liberum Limited ("Panmure Liberum") and Investec Bank plc ("Investec") to execute the Buyback. Costain has entered into a non-discretionary and irrevocable instruction with Panmure Liberum and Investec, pursuant to which Panmure Liberum (in respect of the First Tranche) and Investec (in respect of the Second Tranche) will each purchase the Company's ordinary shares of 1 pence each ("Ordinary Shares") for up to a maximum consideration of £10m for each tranche, each acting severally as riskless principal. The First Tranche will commence immediately. The Second Tranche will commence following completion of the First Tranche and it is anticipated it will end no later than 31 December 2026, subject to market conditions.

The maximum number of Ordinary Shares that can be purchased in aggregate under the First Tranche and Second Tranche is 20,481,508, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2025 annual general meeting (the "2025 AGM") and any subsequent authority.

Panmure Liberum and Investec will make their trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company, within the terms and pre-set parameters of the Buyback.

Any purchase of Ordinary Shares under the Buyback will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The Buyback will be effected under the general authority to repurchase Ordinary Shares granted by the Company's shareholders at the 2025 AGM and in accordance with Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse Regulation.

Any purchase of Ordinary Shares pursuant to the Buyback will be announced by no later the end of the 7th daily market session following the calendar day on which such transaction occurred.

The Company will make further announcements in due course following the completion of any repurchases. There is no guarantee that the Buyback will be implemented in full or that any Ordinary Shares will be repurchased by the Company. The Buyback will not impact the Company's existing Ordinary Share dividend policy, which will continue unaffected through the regular awards of interim and final dividends. At the time of this announcement, the Company's share capital comprises 266,714,895 Ordinary Shares with voting rights.

Enquiries:

 

Investors and analysts matt.jones@costain.com

Matt Jones, Costain +44 (0) 7860 922341

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 (0) 7968 997 365

Charlie Twigg +44 (0) 7946 494 568

 

Notes to editors

 

Costain improves people's lives by creating connected, sustainable infrastructure that enables people and the planet to thrive. Through the delivery of predictable, best-in-class solutions across the transport, water, energy and defence markets, we are creating a sustainable future and securing a more prosperous, resilient and decarbonised UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKLFBQXLLBBZ
Date   Source Headline
5th Jan 20177:01 amRNSAppointment to £500m Major Projects Framework
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20178:00 amRNSTotal Voting Rights
3rd Jan 20178:00 amRNSBlock listing Interim Review
16th Dec 20167:00 amRNSContract
14th Dec 201610:00 amRNSTransfer of Shares
1st Dec 20169:53 amRNSHolding(s) in Company
30th Nov 201610:11 amRNSHolding(s) in Company
30th Nov 20168:00 amRNSTotal Voting Rights
29th Nov 20163:36 pmRNSResult of Placing
29th Nov 20162:42 pmRNSProposed Placing
21st Nov 20167:00 amRNSContract
15th Nov 20167:00 amRNSContract
4th Nov 20161:48 pmRNSDirector/PDMR Shareholding
1st Nov 20169:37 amRNSTotal Voting Rights
31st Oct 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSBlock Listing Application
19th Oct 20164:36 pmRNSDividend Declaration - Amendment
18th Oct 20168:00 amRNSDividend - Scrip Alternative
27th Sep 201612:38 pmRNSDirector/PDMR Shareholding
23rd Sep 201611:06 amRNSHolding(s) in Company
22nd Sep 201611:43 amRNSScrip Dividend Reference Price
20th Sep 201612:57 pmRNSHolding(s) in Company
6th Sep 201612:11 pmRNSDirector/PDMR Shareholding
1st Sep 201612:13 pmRNSHolding(s) in Company
30th Aug 20164:28 pmRNSHolding(s) in Company
30th Aug 20164:08 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSHalf-year Report
11th Jul 201610:16 amRNSDirector Declaration
6th Jul 20167:00 amRNSAcquisition
30th Jun 201612:53 pmRNSDirector/PDMR Shareholding
30th Jun 20168:57 amRNSBlock listing Interim Review
30th Jun 20167:00 amRNSTrading Update
17th Jun 20167:00 amRNSBusiness Briefing
31st May 20169:00 amRNSTotal Voting Rights
17th May 20167:00 amRNSDividend - Scrip Alternative
16th May 20163:03 pmRNSDirector/PDMR Shareholding
5th May 20164:51 pmRNSResult of AGM
5th May 20167:01 amRNSLTIP Listing Application
5th May 20167:00 amRNSAGM Statement
25th Apr 20167:00 amRNSHolding(s) in Company
21st Apr 20162:05 pmRNSScrip Dividend Reference Price
18th Apr 201610:22 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSDirector/PDMR Shareholding
6th Apr 20167:00 amRNSAppointment of Chairman Designate
4th Apr 201610:38 amRNSDirector/PDMR Shareholding
31st Mar 201610:32 amRNSNotice of AGM
2nd Mar 20167:00 amRNSFinal Results
1st Feb 20167:00 amRNSRe Contract
21st Jan 20169:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.